Interferon Gamma-Inducible Protein 16 of Peripheral Blood Mononuclear Cells May Sense Hepatitis B Virus Infection and Regulate the Antiviral Immunity.

Front Cell Infect Microbiol

School of Basic Medical Sciences, Institute of Hepatology and Metabolic Diseases, Key Laboratory of Inflammation and Immunoregulation of Hangzhou, Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University, Hangzhou, China.

Published: January 2022

Interferon gamma-inducible protein 16 (IFI16) is a DNA sensor protein, which triggers interferon-beta (IFN-β) production. However, the role of IFI16 in the innate immunity against hepatitis B virus (HBV) remains controversial. Peripheral blood mononuclear cells (PBMCs) and serum specimens were collected from 20 patients with chronic hepatitis B (CHB) receiving Peg-IFN-α2b therapy. IFI16 mRNA/protein of PBMCs and serum IFI16 at baseline and changes during Peg-IFN-α2b treatment were detected. The interaction between IFI16 and HBV DNA in the PBMCs was analyzed using chromatin immunoprecipitation assay. Leukemic T cell line CEM-C7 and HBV-replicating HepG2.2.15 cells were used to test the effects of interferon treatment and HBV replication on IFI16 expression. Compared with healthy controls, lower levels of mRNA but more significant expression of IFI16 protein with heterogeneous degradation were detected in PBMCs of CHB patients. Early changes in mRNA, but not mRNA of PBMCs or serum IFI16, were correlated to HBeAg seroconversion of Peg-IFN-α2b therapy. An interaction between IFI16 and HBV DNA was detected in the PBMCs. In the cultured HepG2.2.15 and CEM-C7 cells, interferons resulted in the translocalization of IFI16 from the cytoplasm to the nucleus and inhibited IFI16 degradation. IFI16 of PBMCs may play a role in sensing HBV infection, and early change in mRNA of PBMCs is valuable to predict HBeAg seroconversion in Peg-IFN-α2b treatment. The influences on IFI16 degradation and subcellular location may present a molecular mechanism of antiviral activity of interferon.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637547PMC
http://dx.doi.org/10.3389/fcimb.2021.790036DOI Listing

Publication Analysis

Top Keywords

ifi16
13
pbmcs serum
12
interferon gamma-inducible
8
gamma-inducible protein
8
peripheral blood
8
blood mononuclear
8
mononuclear cells
8
hepatitis virus
8
pbmcs
8
peg-ifn-α2b therapy
8

Similar Publications

RNA helicase DDX5 is a host restriction factor for hepatitis B virus (HBV) biosynthesis. Mass spectrometry (LC-MS/MS) identified significant DDX5-interacting partners, including interferon-inducible protein 16 (IFI16) and RBBP4/7, an auxiliary subunit of polycomb repressive complex 2 (PRC2). DDX5 co-eluted with IFI16, RBBP4/7, and core PRC2 subunits in size exclusion chromatography fractions derived from native nuclear extracts.

View Article and Find Full Text PDF

Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.

Am J Physiol Lung Cell Mol Physiol

December 2024

Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Article Synopsis
  • Pulmonary arterial hypertension (PAH) is a disease caused by inflammation and dysfunction in blood vessel cells, leading to changes in the lungs' blood vessels.
  • The study highlights the role of the protein IFI16 in promoting inflammation in these endothelial cells, especially when triggered by the inflammatory molecule IL-1b.
  • Additionally, the research suggests that changes in m6A modification of IFI16 may serve as a potential biomarker for identifying PAH in patients, as increased m6A levels were found in their blood cells compared to healthy controls.
View Article and Find Full Text PDF

Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system, progressing from Relapsing-Remitting MS (RRMS) to Secondary Progressive MS (SPMS) in many cases. The transition involves complex biological changes. Our study aims to identify potential biomarkers for distinguishing SPMS by analyzing gene expression differences between normal-appearing and lesioned parietal grey matter, which may also contribute to understand the pathogenesis of SPMS.

View Article and Find Full Text PDF

EMCV VP2 degrades IFI16 through Caspase-dependent apoptosis to evade IFI16-STING pathway.

Virol J

November 2024

Key Laboratory of Biotechnology and Bioengineering of State Ethnic Biomedical Research Center, Northwest Minzu University, Lanzhou, China.

Interferon (IFN)-γ inducible protein 16 (IFI16), a key DNA sensor, triggers downstream STING-dependent type I interferon (IFN-I) production and antiviral immunity. However, how the IFI16-STING signaling pathway is regulated by EMCV infection is still not well elucidated. In this study, we investigated the interaction between IFI16 and EMCV.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates potential drug targets for endometrial cancer (EC) by using a Mendelian randomization (MR) approach and analyzing data from 12,906 EC cases and 4,907 plasma proteins.
  • - Key analyses included evaluating protein interactions, drug effectiveness, and gene expression, ultimately identifying drug targets for different EC subtypes, including IGF2R and CST3 as significant candidates.
  • - Findings suggest that IGF2R and CST3 may be promising targets for new EC treatments, offering a basis for future clinical strategies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!